Dr Vorstman trained in child and adolescent psychiatry at the University Medical Center, Utrecht, the Netherlands and, as part of his research, in molecular genetics.
Starting in 2001, his research focused on the psychiatric and genetic aspects of the 22q11.2 deletion. Between 2004 and 2006 he worked in the Children’s Hospital of Philadelphia, where he learned the basics of molecular genetics.After obtaining his PhD in 2008, he broadened the scope from 22q11DS to the study of genotype-phenotype relations in autism and schizophrenia.
His ambition is to further insights into the genetic architecture underlying these disorders as well as to improve methods to measure the associated phenotypes. He recently developed a smartphone application for the measurement of social and communicative behaviors, which has receivedconsiderable funding and is currently implemented in several studies generating the first data of this kind.
As of September 2017, Dr Vorstman is appointed as an associate professor at the Hospital for Sick Children. Together with his team of the Autism Research Unit he initiated a clinic for children with genetic risk variants associated with a psychiatric or neurodevelopmental outcome, for which he received CIHR and NIMH funding earlier this year.